Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).

PHASE4CompletedINTERVENTIONAL
Enrollment

311

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DEVICE

Pulmonary function Testing

DRUG

tiotropium bromide

Trial Locations (33)

2910

Hospital de S. Bernardo, Setúbal

3810

Hospital Infante D. Pedro, Aveiro

4300

Hospital Joaquim Urbano, Porto

6200

Centro Hospitalar da Cova da Beira, Covilha

7000

Hospital Espírito Santo, Evora

2800-525 Almada

Hospital Garcia de Orta, Almada

2720-276Amadora

Hospital Fernando Fonseca, Amadora

9700-856

Hospital Santo Espírito de Angra do Heroismo, Angra Do Heroismo - Açores

2830-094

Unidade Funcional de Infecciologia, Barreiro

4701-965

Hospital de S. Marcos, Braga

3000-075

Hospitais da Universidade de Coimbra, Coimbra

3040-853

Centro Hospitalar de Coimbra, Coimbra

8000-386

Hospital Distrital de Faro, Faro

3080-707

Hospital Distrital da Figueira da Foz, Figueira da Foz Municipality

9004-514

Centro Hospitalar do Funchal, Funchal

6300-749

Hospital de Sousa Martins, Guarda

4810-055

Hospital Senhora da Oliveira, Guimarães

1069-142

Hospital Particular de Lisboa, Lisbon

1099-023

Instituto Português de Oncologia Francisco Gentil, Lisbon

1196-024

Hospital de Santa Marta - HCL, Lisbon

1349-019

Hospital Egas Moniz, Lisbon

1649-035

Hospital Santa Maria, Lisbon

1769-001

Hospital Pulido Valente, Lisbon

4454-509

Unidade Local de Saúde de Matosinhos, Matosinhos Municipality

9500-370

Hospital Divino Espírito Santo, Ponta Delgada - Açores

8500-338

Hospital Barlavento Algarvio, Portimão

4050-011

Hospital Geral de Santo António, Porto

4200-319

Hospital de São João, Porto

4520-211

Hospital de S. Sebastião, Santa Maria da Feira

2000-153

Hospital Distrital de Santarém, Santarém

2354-909

Hospital Rainha Santa Isabel, Torres Novas

4434-502

Centro Hospitalar de V. N. de Gaia, V.N.Gaia

3504-509

Hospital de S. Teotónio, Viseu

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00239408 - Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal). | Biotech Hunter | Biotech Hunter